Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM) – PR Inside

Date Posted: February 8th, 2010
Written by
Category: Manufacturing Software

The hepatitis B surface antigen in the HEPLISAV lots being evaluated was produced in Dynavax’s manufacturing facility in Düsseldorf …

View post:
Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM) – PR Inside

Share and Enjoy:
  • Digg
  • del.icio.us
  • email
  • Netvibes
  • Reddit
  • StumbleUpon
  • Technorati
  • Twitter
  • Yahoo! Buzz
Tags: , , , , , , , , , ,
Previous topic:
Next topic:

Leave a Reply

EatonWeb Blog Directory